Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abivax, Aim, Alteogen, Anaptysbio, Aravive, Atea, Cytodyn, Gilead, Imara, Immunitybio, Innovation, Mayne, Merck & Co., Nantkwest, Oncoinvent, Pfizer, Ridgeback, Roche, Seres, Valneva.